Class IOngoing

Mojo Max Fusion XXX recall

FDA recall D-0396-2026 · initiated Oct 8, 2025

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Details

Product: Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Recalling company: Mohamed Hagar
Classification: Class I
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: U.S. Nationwide
Initiated: Oct 8, 2025
FDA report date: Mar 11, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0396-2026 ↗

← All drug recalls